Hereditary pancreatitis and familial pancreatic cancer

Digestion

Volumn 58, Issue 6, 1997, Pages 564-569

  Finch, Margaret D ^a   Howes, Nathan ^a   Ellis, Ian ^a   Mountford, Roger ^a   Sutton, Robert ^a   Raraty, Michael ^a   Neoptolemos, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cationic trypsinogen; Chronic pancreatitis; Genetics; Secondary screening

Indexed keywords

PROTEIN P16; TRYPSINOGEN;

CANCER REGISTRY; CHRONIC PANCREATITIS; CONFERENCE PAPER; GENE MUTATION; HUMAN; MOLECULAR GENETICS; PANCREAS CANCER; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL;

FAMILY HEALTH; HUMANS; PANCREATIC NEOPLASMS; PANCREATITIS; TRYPSINOGEN;

EID: 0030665320     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201502     Document Type: Article

References (47)

1. Whitcomb DC, Gorry MC, Preston RA, Furcv W, Sosscnheinicr MJ, Ulrich CD, Martin SP, Gates LK Jr., Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene, Nat Genet 1996;14:141-145.
2. Hahn SA, Schulte M, Hoquc ATM, Moskaluk CA, da Costa LT, Rozcnhlum E, Weinstein CL, Fischer A, Yco CJ, Hruban RH, Kern SE: DPC4: a candidate tumor suppressor gene at human chromosome 18q21.1, Science 1996: 271:350-353.
3. Achille A, Biasi MO, Zamboni G, Bogina G, Magalina AR, Pederzoli P, Perucho M, Scarpa A: Chromosome 7q allelic losses in pancreatic carcinoma, Cancer Res 1996;56:3808-3813.
4. Le Bodic L, Bignon JD, Raguenes O, Mercier B, Gcorgclin T, Schncc M, Soulard F, Gagne K, Bonneville F, Muller J, Bachner L, Ferec C: The hereditary pancreatitis gene maps to the long arm of chromosome 7, Hum Mol Genet 1996;5:549-554.
5. Rowen L, Koop BF, Hood L: The complete 685-kilobase DNA sequence of the human beta T cell receptor locus, Science 1996:272:1755-1762.
6. Higkaki JN, Light A: Independent refolding of domains in the pancreatic serine proteinascs, J BiolChcm 1986:26:10606-10609.
7. Rovcry M: Limited proteolysis in pancreatic chymotrypsinogens and trypsinogens, Bio-chimie 1988:70:1131-1135.
8. Rinderkncchl H: Pancreatic secretory enzymes: in Go VL, et al, (eds): The Pancreas: Biology, Pathobiology and Disease, ed 2, New York, Raven Press, 1993, pp 219-251.
9. Gorry M, Whitcomb DC, Gates LK Jr., Ulrich CD, Zhang Y, Preston R, Ehrlich GD: Hereditary pancreatitis is associated with multiple mutations in the cationic trypsinogcn gene, Gastroenterology 1997; 112:A445.
10. Caldas C, Kern SE: K-ras mutation and pancreatic adenocarcinoma: State-of-the-art, Int J Pancreatol 1995:18:1-6.
11. Caldas C, Hahn SA, da Costa LT, Redston MS, Schuttc M, Seymour AB, Weinstein C, Hruban RH, Yeo RH, Kern SE: Frequent somatic mutations and homozygous deletions of the p 16 (MTS1) gene in pancreatic adenocarcinoma, Nature Genet 1994:8:27-32.
12. 1NK4 mutations, N Engl J Med 1995:333:970-974.
13. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavitagian SV, Tu-linius H, Ogmundsdottir HM, Evfjord JE: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes, Nature Genet 1996:13: 117-119.
14. Schutte M, Luis T, da Costa LT, Hahn SA, Moskaluk CA, Hoquc ATMS, Rozcnblum E, Weinstein CL, Bittner M, Meltzer P, Trent J, Yeo CJ, Hruban RH, Kern SE: Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region, Proc Natl Acad Sci USA 1995;92:5950-5954.
15. Johansson U, Sellberg C, Brondumniclsen K, Sele V, Olsson H: Founding BRCAI mutations in hereditary breast and ovarian cancer in southern Sweden, Am J Hum Genet 1996:58:441-450.
16. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer, Cancer 1993;71:677-685.
17. Spigelman AD, Farmer KCR, James M, ct al: Tumours of the liver, bile ducts, pancreas and duodenum in a single patient with familial adenomatous polyposis, Br J Surg 1991;78:979-980.
18. Lynch HT: Genetics and pancreatic cancer, Arch Surg 1994;129:266-268.
19. Pipelcers-Marichal M, Somers G, Willem G, et al: Gastrinomas in the duodenum of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome, N Engl J Med 1990:322:723-727.
20. Boden G, Owen OE: Familial hyperglugagon-cmia, an unusual dominant disorder, N Engl J Med 1977:296:634-638.
21. Ldwenfels AB, Maisonncuve P, DiMagno EP, Elitsur Y, Gates LK Jr., Pcrrault J, Whitcomb DC, the International Pancreatitis Study Group: Hereditary pancreatitis and the risk of pancreatic cancer, J Natl Cancer Inst 1997:89:442-446.
22. Hahn SA, Hoque ATM, Moskaluk CA, da Costa LT, Schutte M, Rozcnblum E, Seymour AB, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer, Cancer Res 1996:56:490-494.
23. Schutte M, Kern SE: The molecular genetics of pancreatic carcinoma: in Neoptolcmos JP, Lc-moinc NR (eds): Pancreatic Cancer: Molecular and Clinical Advances, Oxford, Blackwell Science, 1996, pp 115-132.
24. Hahn SA, Seymour AB, Hruban RH, Yeo J, Kern SE: Multiple sites of allelic loss in pancreatic carcinoma, Am J Gastroenterol 1994: 106:A390.
25. Lynch HT, Smyrk T, Kern SE, Hruban RH, Lightdale CJ, Lynch JF, Fusaro LR, Fusaro R1I, Ghadirian P: Familial pancreatic cancer: A review, Semin Oncol 1996:23:251-275.
26. Lumadue JA, Griffin CA, Osman M, Hruban RH: Familial pancreatic cancer and the genetics of pancreatic cancer, Surg Clin N Am 1995; 75:845-855.
27. Ward JB, Petersen OH, Jenkins SA, Sutton R: Is an elevated concentration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis? Lancet 1995:346:1016-1019.
28. Ward JB, Sutton R, Jenkins SA, Petersen OH: Progressive disruption of acinar cell calcium signalling is an early feature of cerulein-in-duccd pancreatitis in mice, Gastroenterology 1996;111:481-491.
29. Iwatsuki N, Petersen OH: Acctvlcholinc-like effects of intracellular calcium application in pancreatic acinar cells, Nature 1977:268:147-149.
30. Steer ML: How does acute pancreatitis begin? Arch Surg 1992;127:1350-1353.
31. Schmid SW, Modlin IM, Carangelo MN, Katz A, Stoch S, Rhee GA, Scheele FS, Gorclick FS: Telenzepine sensitive acinar cell receptors mediate muscarinic stimulated secretion and zymogen processing, Gastroenterology 1997:112: A480.
32. Comfort MW, Gambil EE, Baggenstoss AH: Chronic relapsing pancreatitis, Gastroenterology 1946:6:239-285, 376-408.
33. Sarles H: Pancreatitis, Symposium in Marseilles, April 25 and 26, 1963; in Sarles H (ed): Biblthea Gastroenterol, Basel, Karger, 1965, Iasc 7.
34. Sarles H: Pathogenesis of chronic pancreatitis, Gut 1990:31:629-632.
35. Klöppel G, Maillet B: Pseudocysts in chronic pancreatitis: A morphological analysis of 57 specimens and 9 autopsy pancrcata, Pancreas 1991:5:266-274.
36. Löwcnfels AB, Maisonneuvc P, Cavallini G, Ammann RW, Lankisch PG, Anderson JR, DiMagno EP, Andren-Sandberg A, Dommellof L: Pancreatitis and the risk of pancreatic cancer, N Engl J Med 1993;328:1433-1437.
37. Gold EB, Cameron JL: Chronic pancreatitis and pancreatic cancer (letter), N Engl J Med 1993;328:1485-1486.
38. Scarpelli DG, Rao MS, Reddy JK: Are pancreatic acinar cells involved in the pathogenesis of ductal adenocarcinoma of the pancreas? Cancer Cells 1991:3:275-277.
39. Komorowski RA, Tresp MG, Wilson SD: Pan-creato-biliary involvement in familial polyposis coli/Gardeners syndrome, Dis Colon Rectum 1986;29:55-58.
40. DiGiuscppe JA, Hruban RH, Offerhaus GJ, Clement MJ, van den Berg FM, Cameron JL, Vamansfield ADM: Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma, Am J Pathol 1994:155:889-895.
41. Lcmoine NR, Jain S, Hughes CM, Straddon SC, Maillet B, Hall PA, Klöppel G: K-ras oncogene activation in preinvasive pancreatic cancer, Gastroenterology 1992:102:230-236.
42. Ruggcri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H: The molecular pathology of primary and metastatic ductal pancreatic lesions: Analysis of mutations and expression of the p53, mdmd-2, and p21/WAF-l genes in sporadic and familial lesions, Cancer 1996;79:700-716.
43. Banerjee AK, Galloway SW, Kingsnorth AN: Experimental models of acute pancreatitis, Br J Surg 1994;81:1096-1103.
44. Kingsnorth AN, Galloway SW, Formela U: Randomised, double-blind phase II trial of lex-ipalar.t, a platelet activating factor antagonist, in human acute pancreatitis, Br J Surg 1995:82: 1414-1420.
45. Giardiello FM, Offerhaus GJA, Lee DH, Krusl AJ, Tersmette AC, Booker SV, Kelley NC, Hamilton SR: Increased risk of thyroid and pancreatic-carcinoma in familial adenomatous polyposis, Gut 1993:34:1394-1396.
46. Iguchi H, Sugano K, Fukayama N, Ohkura H, Sadamoto K, Ohkoshi K, Seo Y, Tomoda H, Funakoshi A, Wakasugi H: Analysis of K-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer, Gastroenterology 1996:110:221-226.
47. Dib C, Faure S, Fizamcs C, et al: A comprehensive gcnctic-map of the human genome based on 5.264 microsatellites, Nature 1996:380: 152-154.